XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY AND MEZZANINE EQUITY - USD ($)
Total
Preferred Stock
Common Stock
Treasurys Stocks
Additional Paid-In Capital
Subscription Receivable
Retained Earnings (Accumulated Deficit)
Accumulated other comprehensive loss
Balance, shares at Dec. 31, 2022     10,605,412 15,497        
Balance, amount at Dec. 31, 2022 $ 39,284,295 $ 372,414 $ 10,606 $ (816,707) $ 112,205,952 $ (4,750,108) $ (66,232,813) $ (1,132,635)
Foreign currency translation adjustment, net 336,463             336,463
Proceeds from sale of common stock 4,750,000         4,750,000    
Shares issued in lieu of cash, shares     15,258          
Shares issued in lieu of cash, amount 96,888   $ 15   96,873      
Net loss (459,863)           (459,863)  
Balance, shares at Mar. 31, 2023     10,620,670 15,497        
Balance, amount at Mar. 31, 2023 44,007,783 372,414 $ 10,621 $ (816,707) 112,302,825 (108) (66,692,676) (796,172)
Balance, shares at Dec. 31, 2023     15,982,472 86,497        
Balance, amount at Dec. 31, 2023 36,043,028 0 $ 15,983 $ (917,159) 129,008,301 (20) (91,644,233) (419,844)
Foreign currency translation adjustment, net (599,276) 0 0 0 0 0 0 (599,276)
Shares issued in lieu of cash, amount 108,297 0 0 0 108,297 0 0 0
Net loss (1,866,690) 0 $ 0 0 0 0 (1,866,690) 0
Proceeds from sale of common stock, net of financing fees of $19,467, shares     901,488          
Proceeds from sale of common stock, net of financing fees of $19,467, amount 629,426 0 $ 901 0 628,525 0 0 0
Shares issued pursuant to warrant exchange agreement, shares     950,063          
Shares issued pursuant to warrant exchange agreement, amount 0 0 $ 950 0 (950) 0 0 0
Stock-based compensation 231,897 0 $ 0 $ 0 231,897 0 0 0
Balance, shares at Mar. 31, 2024     17,834,023 86,497        
Balance, amount at Mar. 31, 2024 $ 34,546,682 $ 0 $ 17,834 $ (917,159) $ 129,976,070 $ (20) $ (93,510,923) $ (1,019,120)